FDA Summary

2/21/01


Click here to start


Table of Contents

FDA Summary

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

Clinical Data

Primary Response Variable

Patient Enrollment

Inclusion Criterion Change

Two Similar RCTs

Patient Characteristics

Lesion Characteristics

Different Treatment Effects

Possible Causes of the Different MACE Rates

Panel Questions

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

PPT Slide

Author: spykers